Ultragenyx Pharmaceutical RARE
NASDAQ RARE
$14.75 -0.28 (-1.86%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ultragenyx Pharmaceutical (RARE) Other Non-Current Assets (2013 - 2026)

Updated

Ultragenyx Pharmaceutical's Other Non-Current Assets came in at $63 million for Q2 2026, up 4.8% from $60.12 million a year earlier and up 3.3% from the prior quarter.

Analysis

Ultragenyx Pharmaceutical (RARE) Other Non-Current Assets (2013 - 2026) Analysis & Trends

At the end of FY2025, Ultragenyx Pharmaceutical's Other Non-Current Assets was $60 million, down 4.8% from FY2024.

  • Other Non-Current Assets carries a five-year compound annual growth rate of 46.8% (FY2020 to FY2025).
  • Going back by year, Other Non-Current Assets was $63 million in FY2024 (+9.2%), $57.69 million in FY2023 (+19.3%), $48.34 million in FY2022 (+135.1%) and $20.56 million in FY2021 (+133.3%).
  • Year-over-year, Other Non-Current Assets increased in six of the last eight quarters, with growth averaging 15.4%.
  • The fastest year-over-year change in Other Non-Current Assets over five years came in Q3 2021 (growth of 222.4%), and the weakest in Q4 2025 (a decline of 4.8%).
  • Business Quant data shows RARE's Other Non-Current Assets at $61 million (Q1 2026), $60 million (Q4 2025) and $57.86 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Ultragenyx Pharmaceutical 1.48 Bn -321.29 Mn 180.00 Mn 63.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 63.00 Mn
Mar 31, 2026 61.00 Mn
Dec 31, 2025 60.00 Mn
Sep 30, 2025 57.86 Mn
Jun 30, 2025 60.12 Mn
Mar 31, 2025 62.37 Mn
Dec 31, 2024 63.00 Mn
Sep 30, 2024 53.87 Mn
Jun 30, 2024 53.77 Mn
Mar 31, 2024 59.97 Mn
Dec 31, 2023 57.69 Mn
Sep 30, 2023 27.90 Mn
Jun 30, 2023 26.49 Mn
Mar 31, 2023 22.26 Mn
Dec 31, 2022 48.34 Mn
Sep 30, 2022 18.29 Mn
Jun 30, 2022 21.14 Mn
Mar 31, 2022 21.22 Mn
Dec 31, 2021 20.56 Mn
Sep 30, 2021 16.42 Mn
API Access

Ultragenyx Pharmaceutical Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=RARE&period=max&api_key=YOUR_API_KEY